Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 78
Healthy volunteers: yes

Brief summary:
The aim of this study is to investigate the safety and tolerability of BI 655130 in healthy male subjects following single rising low, medium and high doses.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: BI 655130 (spesolimab) intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: